Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
12.40
-0.42 (-3.28%)
At close: Feb 4, 2026, 4:00 PM EST
12.10
-0.30 (-2.42%)
After-hours: Feb 4, 2026, 5:41 PM EST
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $514.85 million as of February 4, 2026. Its market cap has increased by 203.38% in one year.
Market Cap
514.85M
Enterprise Value
347.44M
1-Year Change
203.38%
Ranking
Category
Stock Price
$12.40
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $514.85M, a decrease of -60.37%. That is a compound annual growth rate of -16.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 514.85M | 1.66% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 520.62M |
| LENZ Therapeutics | 510.03M |
| Solid Biosciences | 500.96M |
| Alto Neuroscience | 491.16M |
| Invivyd | 490.66M |
| Niagen Bioscience | 487.74M |
| ADC Therapeutics | 483.12M |
| Verastem | 482.39M |